Healthcare & Life Sciences
Promedior
United Statespromedior.com
Promedior is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Promedior
Promedior is a company headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Promedior is a clinical-stage biotechnology company developing targeted therapeutics to treat diseases involving fibrosis, including severe fibrotic and inflammatory conditions such as idiopathic pulmonary fibrosis (IPF).
Explore Promedior's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.